Morning Overview on MSN
A gene therapy injected straight into brain tumors just began dosing its first patients — a virus engineered to kill glioblastoma cells and spare the rest
Somewhere in an operating room this spring, a neurosurgeon did something that has never been done before: while removing a ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2026 update of AACE’s consensus statement algorithm ...
The biggest stories of the day delivered to your inbox.
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
ARLINGTON, Va.--(BUSINESS WIRE)--Today, Venture Global, Inc. (NYSE: VG) is announcing a final investment decision (FID) and successful closing of an $8.6 billion project financing for the second phase ...
AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results